These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7230409)

  • 1. Contempo '81. Trends in regulation and development of new drugs.
    Ballin JC
    JAMA; 1981 Jun; 245(21):2161-3. PubMed ID: 7230409
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Designer Drug' Enforcement Act seeks to attack problem at source.
    Hagerty C
    Am Pharm; 1985 Oct; NS25(10):10-1. PubMed ID: 4061277
    [No Abstract]   [Full Text] [Related]  

  • 3. The regulation of drugs and biologics: fifty years into the future.
    Kuhlik BN
    Food Drug Law J; 2000; 55(1):21-5. PubMed ID: 12269358
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer-causing substances in food, drugs, and cosmetics. The de minimis rule versus the Delaney clause.
    Curran WJ
    N Engl J Med; 1988 Nov; 319(19):1262-4. PubMed ID: 3273488
    [No Abstract]   [Full Text] [Related]  

  • 5. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical pharmacologist in drug regulation: the US perspective.
    Temple RJ
    Br J Clin Pharmacol; 1996 Jul; 42(1):73-9. PubMed ID: 8807147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic variation in drug response: implications for the development and regulation of drugs.
    Johnson DE; Park BK; Smith DA
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):29-31. PubMed ID: 18175264
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed consent--a new approach to drug regulation?
    Nutt DJ
    J Psychopharmacol; 2006 Jan; 20(1):3-4. PubMed ID: 16354734
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA gathers information for plans to regulate nanoscale drugs.
    Lavine G
    Am J Health Syst Pharm; 2008 Nov; 65(21):1988, 1990. PubMed ID: 18945848
    [No Abstract]   [Full Text] [Related]  

  • 10. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical trademarks: navigating through the FDA's pilot program.
    Ferrer E
    Drug News Perspect; 2010 Jun; 23(5):333-6. PubMed ID: 20603657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug licensing or innovation.
    Lancet; 1981 Oct; 2(8250):788. PubMed ID: 6116910
    [No Abstract]   [Full Text] [Related]  

  • 13. [The concept of determining national requirements of essential drugs].
    Meshkovskiĭ AP
    Sov Zdravookhr; 1990; (11):62-5. PubMed ID: 2075502
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory evaluation of biotechnology drugs: current trends in the United States.
    Sobel S
    Bioprocess Technol; 1991; 13():499-511. PubMed ID: 1367148
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 16. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].
    Stephan K
    Pharm Unserer Zeit; 2011 Jul; 40(4):300-4. PubMed ID: 21698627
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.
    Gaspar R
    Nanomedicine (Lond); 2007 Apr; 2(2):143-7. PubMed ID: 17716116
    [No Abstract]   [Full Text] [Related]  

  • 19. China takes first steps toward healthcare and drug reforms.
    Hughes V
    Nat Med; 2008 Nov; 14(11):1132. PubMed ID: 18989266
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulations which govern the availability of therapeutic drugs in Australia.
    Shaw J
    J Clin Pharmacol; 1988 Oct; 28(10):889-93. PubMed ID: 3220963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.